September 2023 - Page 14 of 20

TuesdaySep 12, 2023 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Investigational Research Programs Position the Company for Important Partnership Opportunities and Growth

Lexaria Bioscience has completed several studies that confirm and support the superiority and advantages of its patented DehydraTECH(TM) technology over traditional oral delivery methods The company recently announced results from its human oral nicotine study NIC-H22-1 comparing its DehydraTECH-nicotine pouch to world-leading brands, Zyn(R) and on!(R) Results from the study demonstrated that DehydraTECH-nicotine was statistically significantly faster in reaching Tmax than both brands Lexaria has also undertaken other investigational research programs, including the analysis and execution of hypertension, diabetes, hormone therapy, and dementia studies, which could birth excellent partnership opportunities, supporting further growth A report by Zacks Investment Research discussed…

MondaySep 11, 2023 2:13 pm

QualityStocksNewsBreaks – SOHM Inc. (SHMN) Names Seasoned Veteran as VP of Quality

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has appointment a new vice president of quality. The company announced that Wm. Dewey Rushing will be serving as SOHM vice president for quality. Rushing has been serving on the company’s advisory board member and that experience combined with his impressive background in management and leadership make him ideally qualified for his new role. A well-known expert in the field of pharmaceutical quality validation and cGMP compliance, Rushing has a resume that includes cell therapy IND readiness, quality systems audits, aseptic…

MondaySep 11, 2023 1:05 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Strategic Acquisition of Romeo Power Assets

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its purchase of battery pack production assets from Romeo Power for approximately $3.5 million. According to the announcement, the deal includes equipment, inventory and intellectual property for high volume EV battery pack and module production. The assets include production lines for EV pack assembly and precision R&D module and pack development with associated inventory allowing for production of modules and vehicle battery packs. In addition, the purchased assets include battery testing and validation equipment, computer numerical control (“CNC”) equipment for battery pack and module enclosure production. “Purchasing the…

MondaySep 11, 2023 12:18 pm

QualityStocksNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) to Begin Deer Horn Drill Program, Announces Private Placement Financing

First Tellurium (CSE: FTEL) (OTCQB: FSTTF) has scheduled its drill program in Deer Horn to begin later this month; the program will focus on the Pond zone copper-gold porphyry target. According to the announcement, the objective of the program will be to intersect disseminated mineralization and help locate the main mineral zone in the subsurface. Information obtained from the program will be combined with results from work conducted over the past two years to inform a larger drill program scheduled for 2024. The company will also be conducting an Induced Polarization (“IP”) geophysical survey this month, which will be following up on…

MondaySep 11, 2023 12:00 pm

Shoals Technologies Group, Inc. (NYSE: SHLS) Featured in Coverage of the ROTH MKM 10th Annual Solar & Storage Symposium

Shoals Technologies Group (NYSE: SHLS) is a leading provider of electrical balance of systems (“EBOS”) solutions for solar, storage, and electric vehicle charging infrastructure. Since its founding in 1996, the company has introduced innovative technologies and systems solutions that allow its customers to substantially increase installation efficiency and safety while improving system performance and reliability. Shoals Technologies Group, Inc. is a recognized leader in the renewable energy industry whose solutions are deployed on over 62 GW of solar systems globally. For more information, visit the company's website at www.Shoals.com. To schedule a one-on-one meeting, please contact your ROTH MKM representative. To…

MondaySep 11, 2023 11:22 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation in H.C. Wainwright, LSX USA Congress 2023 and Upcoming Conferences

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company formerly known as BiondVax Pharmaceuticals Ltd., today announced that its CEO Amir Reichman and Chairman of the Board Mark Germain will be attending the H.C. Wainwright 25th Annual Global Investment Conference in New York today and tomorrow (Sept. 11 and 12) and the LSX USA Congress 2023 in Boston this Wednesday and Thursday (Sept. 13 and 14). Investors and potential business partners interested in meeting with Reichman and Germain are invited to contact Scinai investor relations at ir@scinai.com to request a meeting. In addition, members of Scinai’s senior leadership team will be attending…

MondaySep 11, 2023 11:15 am

SuperCom Ltd. (NASDAQ: SPCB) Offers its Newest Solution for Increasing Public Safety, Reducing Domestic Violence, While Cutting Government Costs

SuperCom has introduced the all-in-one PureOne monitoring device with three unique tech modules, offering advanced technology for the cost-effective electronic home and civil monitoring of offenders The electronic offender monitoring market in Europe and the Americas is expected to reach $2.1 billion in 2026 and is seeking new technologies to meet a rapidly growing demand SuperCom’s innovative solutions promise a critical technological and social impact – improving public safety worldwide and reducing governmental costs in the process The company’s growth strategy includes potential acquisitions and expansion into new regions with limited electronic monitoring capabilities SuperCom (NASDAQ: SPCB), a leading global…

MondaySep 11, 2023 10:49 am

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) CEO Releases Stockholder Letter

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has issued a letter to its stockholders. The letter, from CEO Wa’el Hashad, contains a business update regarding the company’s development of its lead investigational product, Lomecel-B(TM), as well as steps taken to strengthen the board and executive team along with details regarding the current rights offering. The letter noted that Longeveron is involved in ongoing trials of Lomecel-B, a living cell product made from specialized cells isolated from the bone…

MondaySep 11, 2023 10:15 am

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Closes on Nonbrokered Private Placement, Announces Debt Conversion Details

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has closed a nonbrokered private placement among other financial announcements. The private placement was comprised of 6,741,000 units at $0.06 per unit, resulting in gross proceeds of $404,460 for the company. According to the announcement, each unit consisted of one common share of the company along with one common share purchase warrant allowing holders to purchase an additional common share at an exercise price of $0.09 until today. FuelPositive anticipates using the funds for further development of its demonstration systems for…

MondaySep 11, 2023 9:45 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) to Attend H.C. Wainwright 25th Annual Global Investment Conference and Discuss UPNEEQ(R) for Treating Acquired Blepharoptosis

RVL Pharmaceuticals' CEO Brian Markison and COO JD Schaub will participate in a fireside chat and 1-on-1 investor meetings on Tuesday, September 12, 2023, during this year's H.C. Wainwright Annual Global Investment Conference in New York City The company will discuss UPNEEQ(R) and its use as the first non-surgical treatment option approved by the FDA for acquired blepharoptosis RVL Pharmaceuticals plans to continue marketing to medical aesthetics providers and will launch a direct-to-consumer campaign later this year The medical aesthetics market was valued at $13.9 billion in 2022 and is expected to reach $23.4 billion by 2027 RVL Pharmaceuticals (NASDAQ:…

Site Search

Company Search

Month: September 2023